Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH902 for Diabetic Macular Edema Phase II Study
CTR20131418Phase 2Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Mar 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in diabetic macular edema (DME), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Mar 2014; status: completed.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20131418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131418.